PARP1 can also modify several chromatin-remodeling factors, including Spt16 in the FACT (facilitates chromatin transcription) complex [
33,
34] and the nucleosome remodeling ATPases, ISWI [
35] and ALC1(amplified in liver cancer 1) [
14,
36]. The FACT complex, a heterodimer of hSpt16 and SSRP1, is associated with the nucleosome and facilitates transcription elongation by removing one H2A-H2B dimer to enable the passage of pol II through the chromatin [
37]. Upon DNA damage, poly(ADP-ribosyl)ation of Spt16 disrupts the association of FACT with the nucleosome and inhibits FACT-mediated exchange of histone variant H2AX with canonical H2A [
33,
34]. In addition, ATP-dependent nucleosome remodeling complexes, including ISWI and ALC1, modulate chromatin structure by nucelosome sliding [
14,
38]. An unbiased genetic screen showed that the
Parp1 and
Parg mutations enhanced the rough-eye phenotype caused by eye-specific expression of the dominant negative allele
ISWIk159R, suggesting the genetic interaction between
ISWI and
PARP1 or
PARG genes [
35,
39]. Biochemical assays showed that ISWI can be poly(ADP-ribosyl)ated
in vitro and that poly(ADP-ribosyl)ated ISWI can be detected
in vivo (). It appears that poly(ADP-ribosyl)ation inhibits the ATPase activity of ISWI and further reduces its binding affinity for nucleosomes [
35]. It has been shown
in vivo that ISWI can promote histone H1 binding to chromatin and thus help to compact it [
40]. However, since H1 also competes with PARP1 for binding to the gene promoters [
21], poly(ADP-ribosyl)ation of ISWI may actually counteract H1 binding by relaxing chromatin after PARP1 activation (). In addition, two independent studies suggested that pADPr can bind with ALC1 (amplified in liver cancer 1) through its macrodomain by an
in vitro binding assay [
14,
36]. In contrast to the inhibition of ISWI ATPase activity and binding affinity for nucleosomes by poly(ADP-ribosyl)ation [
35], PARP1-mediated pADPr binding with ALC1 strongly stimulated its ATPase and nucleosome-sliding activities and helped to recruit ALC1 to DNA damage sites, possibly for the purpose of relaxing chromatin [
14,
36]. Notwithstanding these findings, the mechanism underlying the stimulation of ALC1 activity by automodified PARP is not entirely understood. However, since the nucleosome-sliding ability of ALC1 is dependent on H4 tail, we speculate that destabilization of mononucleosomes by automodified PARP may expose the histone H4 tail, thus allowing interaction with ALC1 for its activity
in vivo [
14]. Therefore, besides histone and its variants, it is clear that activated PARP1 also can interact with, and modulate the activities of, a number of nucleosome-remodeling factors to further destabilize chromatin and facilitate transcription activation ().